Showing results (91-100 of 105) with videos related to

Sort By:
Pageof 11
Respiratory Medicine|October 21, 2022
Early chronic obstructive pulmonary disease: Associations of two spirometry criteria with clinical featuresFumi Mochizuki, Naoya Tanabe, Hiroaki Iijima, et al.
ERJ Open Research|March 6, 2024
Centrilobular emphysema and airway dysanapsis: factors associated with low respiratory function in younger smokersFumi Mochizuki, Naoya Tanabe, Takafumi Shimada, et al.
Medical Oncology (Northwood, London, England)|November 1, 2008
A population-based study of gefitinib in patients with non-small cell lung cancerKenji Hayashibara, Hiroaki Satoh, Yoko Shinohara, et al.
Molecular and Clinical Oncology|June 11, 2016
S-1-containing chemotherapy for patients with non-small-cell lung cancer: A population-based observational study by the Ibaraki thoracic integrative (POSITIVE) research groupMasaharu Inagaki, Yoko Shinohara, Takayuki Kaburagi, et al.
Anticancer Research|September 29, 2023
Atezolizumab for EGFR-mutated Non-small Cell Lung Cancer Patients: An Observation Study in Ibaraki Group (ATTENTION-IBARAKI)Tomohiro Tamura, Takeshi Numata, Hidetoshi Yanai, et al.
Arerugi = [Allergy]|December 15, 2015
[FACTORS ASSOCIATED WITH THE PRESENCE OF ALLERGEN-SPECIFIC IgE RESPONSES IN ASTHMA PATIENTS WHO HAD NO IgE RESPONSES DETECTABLE BY MAST-26]Hiroaki Iijima, Yoshiko Kaneko, Hironori Masuko, et al.
In Vivo (Athens, Greece)|August 31, 2023
Atezolizumab Monotherapy for Non-small Cell Lung Cancer Patients: An Observational Study in Ibaraki Group (ATTENTION-IBARAKI)Shinichiro Okauchi, Gen Ohara, Toshihiro Shiozawa, et al.
Medical Oncology (Northwood, London, England)|November 3, 2012
Bevacizumab-containing chemotherapy for non-small cell lung cancer patients: a population-based observational study by the Ibaraki thoracic integrative (POSITIVE) research groupHiroyuki Nakamura, Hiroaki Satoh, Takayuki Kaburagi, et al.
In Vivo (Athens, Greece)|July 2, 2020
Serum CEA and CYFRA Levels in ALK-rearranged NSCLC Patients: Correlation With Distant MetastasisTakeshi Numata, Takeo Endo, Hidetoshi Yanai, et al.
Oncology Letters|February 20, 2013
Observational study on the efficacy and safety of erlotinib in patients with non-small cell lung cancerTakayuki Kaburagi, Hiroaki Satoh, Kenji Hayashihara, et al.
Pageof 11